Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Neuromodulation of Memory in Aging

NCT: NCT05460468 · RECRUITING

NCT IDNCT05460468
StatusRECRUITING
Start Date2024-03-28
Completion2027-06-30
SponsorIndiana University (OTHER)
First posted
Last updated

Brief Summary

The proposed research will use closed-loop transcranial magnetic stimulation (TMS) based on individualized brain networks to establish parameters that can reliably control brain states. This will be tested in healthy aging and mild cognitive impairment (MCI) cohorts. The investigators will study network activation and neural oscillatory mechanisms underlying the network that regulates working memory and then target this network using closed-loop TMS to the Prefrontal Cortex. Investigators will measure the impact of TMS on working memory performance and task-based neural activity. The project will use brain stimulation and network modeling techniques to enhance working memory in healthy older adults and MCI and will demonstrate the value of closed-loop, network-guided TMS for future clinical applications.

Frequently Asked Questions

What is Neuromodulation of Memory in Aging?

Neuromodulation of Memory in Aging is a clinical trial registered under NCT05460468. Current status: RECRUITING.

What is the status of NCT05460468?

The current status of NCT05460468 (Neuromodulation of Memory in Aging) is: RECRUITING.

When did Neuromodulation of Memory in Aging start?

Neuromodulation of Memory in Aging started on 2024-03-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.